key: cord-0735146-x5al3jhg
authors: Wong, D. W. L.; Klinkhammer, B. M.; Djudjaj, S.; Villwock, S.; Timm, M. C.; Buhl, E. M.; Wucherpfennig, S.; Cacchi, C.; Braunschweig, T.; Knüchel-Clarke, R.; Jonigk, D.; Werlein, C.; Bülow, R. D.; Dahl, E.; von Stillfried, S.; Boor, P.
title: Multisystemic cellular tropism of SARS-CoV-2 in autopsies of COVID-19 patients
date: 2021-06-05
journal: nan
DOI: 10.1101/2021.06.03.21258241
sha: 142cd0c341d66716af460c6fe3d881fcb43f34a5
doc_id: 735146
cord_uid: x5al3jhg

Background: Multiorgan tropism of SARS-CoV-2 has previously been shown for several major organs. Methods: We have comprehensively analyzed 25 different formalin-fixed paraffin-embedded (FFPE) tissues/organs from autopsies of fatal COVID-19 cases (n=8), using detailed histopathological assessment, detection of SARS-CoV-2 RNA using polymerase chain reaction and RNA in situ hybridization, viral protein using immunohistochemistry, and virus particles using transmission electron microscopy. Finally, we confirmed these findings in an independent external autopsy cohort (n=9). Findings: SARS-CoV-2 RNA was mainly localized in epithelial cells, endothelial and mesenchymal cells across all organs. Next to lung, trachea, kidney, heart, or liver, viral RNA was also found in tonsils, salivary glands, oropharynx, thyroid, adrenal gland, testicles, prostate, ovaries, small bowel, lymph nodes, skin and skeletal muscle. Viral RNA was predominantly found in cells expressing ACE2, TMPRSS2, or both. The SARS-CoV-2 replicating RNA was also detected in these organs. Immunohistochemistry and electron microscopy were not suitable for reliable and specific SARS-CoV-2 detection in autopsies. The findings were validated using in situ hybridization on external COVID-19 autopsy samples. Finally, apart from the lung, correlation of virus detection and histopathological assessment did not reveal any specific alterations that could be attributed to SARS-CoV-2. Conclusion: SARS-CoV-2 could be observed in virtually all organs, colocalizing with ACE2 and TMPRSS2 mainly in epithelial but also in mesenchymal and endothelial cells, and viral replication was found across all organ systems. Apart from the respiratory tract, no specific (histo-)morphologic alterations could be assigned to the SARS-CoV-2 infection.

Evidence before this study SARS-CoV-2 has been shown to infect the respiratory tract and affect several other major organs. However, on a cellular level, the localization of SARS-CoV-2 and its targets ACE2 and TMPRSS2 have not been described comprehensively.

We have analyzed tissue SARS-CoV-2 RNA using RT-PCR and visualized its localization together with ACE2 and TMPRSS2 using in situ hybridization (ISH) in 25 different autopsy tissues. SARS-CoV-2 sense and antisense RNA were detected in 16 tissues/organs, mainly in epithelial cells and, to a lesser extent, in endothelial or stromal cells. Detection of viral protein using immunohistochemistry or viral particles using transmission electron microscopy did not yield specific results. Interestingly, apart from the respiratory tract and specifically the lungs, we have not found a specific pathology that would be associated with extrapulmonary viral spread.

We provide a recommendation on using these methods in autopsy diagnostics for SARS-CoV-2. Our data extend the current hypothesis of severe COVID-19 being multisystemic diseases. Our data also provide clear evidence of infection and replication of SARS-CoV-2 in the endothelial cell across all organs, extending the hypothesis on the (micro)vascular involvement in COVID-19.

Since late 2019, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causing the Coronavirus Disease 2019 (COVID- 19) has caused a pandemic with major impacts on virtually all aspects of life. By May 2021, the number of global deaths attributed to COVID-19 has increased to more than 3 million, with more than 160 million infected individuals in 223 countries (WHO; https://covid19.who.int/).

Despite extensive research, understanding of the organic and cellular manifestations of COVID-19 remains incomplete. Next to the typical clinical symptoms of a respiratory infection 1 , including fever, dyspnea, and dry cough, other symptoms indicate the involvement of other organ systems, e.g., diarrhea, vomiting, or anosmia.

In severe cases, patients develop acute respiratory distress syndrome (ARDS), pneumonia but also systemic inflammation, heart diseases (e.g. elevated cardiac markers, acute heart failure) 2 , and acute kidney injury (AKI). These data suggest that COVID-19 can be viewed as a multisystemic disease.

Post-mortem investigation, i.e., autopsy, provides a comprehensive insight into the pathophysiology of novel diseases, such as COVID-19, allowing investigation of the multisystemic viral spread and effects on a tissue and cellular level 3 . Recent studies using in situ hybridization (ISH) have found SARS-CoV-2 tropism and replication in airways, i.e., trachea, lung, bronchi, or submucosal glands, within pneumocytes, alveolar and pulmonary lymph node macrophages, endothelium, and respiratory epithelium [4] [5] [6] [7] [8] [9] [10] [11] . In extra-respiratory organs, ISH demonstrated direct infection of vascular endothelium in the kidney (renal proximal and distal tubular epithelial cells) 9, [12] [13] [14] , heart 10 , liver 9 , brain stem and leptomeninges 9 and placenta (syncytiotrophoblast and cytotrophoblast) 15 . However, the tissue and cellular association of SARS-CoV-2 genomic sense RNA and antisense RNA (indicating All rights reserved. No reuse allowed without permission.

(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted June 5, 2021. ; https://doi.org/10.1101/2021.06.03.21258241 doi: medRxiv preprint replication), with the receptor and protease required for viral entry into the cells, i.e. angiotensin-converting enzyme 2 (ACE2) and transmembrane protease serine subtype 2 (TMPRSS2), across the various tissues were not comprehensively described 16 . Here, we used a multitude of different methods to analyze the distribution of SARS-CoV-2 virus, ACE2, and TMPRSS2 in 25 different organs, using formalin-fixed paraffin-embedded (FFPE) autopsy specimens from deceased COVID-19 patients.

All rights reserved. No reuse allowed without permission.

(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted June 5, 2021. ; https://doi.org/10.1101/2021.06.03.21258241 doi: medRxiv preprint

The study was approved by the local ethics committee (EK 304/20, EK 119/20, EK 092/20 and 9621_BO_K_2021) and was carried out in accordance with the declaration of Helsinki for medical research involving human subjects. For all autopsies, legal authorization was obtained from the next of kin of the deceased person.

We used tissue collected from eight autopsies (Table 1 ). At the time of death, patients were 68±9·55 years old and predominantly male (M:F = 5:3). All patients tested positive for SARS-CoV-2 by RT-PCR during their clinical course. After death, corpses were cooled at 4°C from 4 h after death until autopsy. The post-mortem interval (i.e., time from death to autopsy) ranged from 20 to 48 h (median, 35·5 h).

Autopsies were performed in a dedicated room equipped with a separate ventilation system. All autopsies were performed in two steps, with internal organs removed first and then fixed in 4% buffered formalin and without brain autopsy to avoid aerosol formation. Organs were fixed for one week before further processing. Then, all organs from the thorax and abdomen were examined macroscopically and microscopically (tongue, oropharynx, tonsil, salivary gland, thyroid, proximal and distal trachea, paraaortal/ cervical/ hilar/ abdominal lymph nodes, each lung lobe (one central and one peripheral sample each), heart (anterior, lateral and posterior left ventricular wall, septum, left ventricular papillary muscles, and right ventricle), esophagus, stomach, small intestine, colon, left and right liver lobes, pancreas, spleen, left and right kidney, left and right adrenal gland, uterus (f)/ prostate (m), ovary (f)/ testis (m), muscle, and skin. Personal protective equipment included N95 All rights reserved. No reuse allowed without permission.

(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted June 5, 2021. ; https://doi.org/10.1101/2021.06.03.21258241 doi: medRxiv preprint masks, waterproof protective suits, goggles, waterproof aprons, and multiple layers of gloves. All garments were changed before and after autopsies were performed. The detailed protocol of the autopsy procedure is available at https://www.pathologiedgp.de/media/Dgp/aktuelles/Anl._3_Obduktion_COVID-19_15042020__1_.pdf (in german). We have also used an independent validation cohort of nine cases described in detail in the supplementary methods.

For microscopic examination, all formalin-fixed specimens were dehydrated and (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted June 5, 2021. ; https://doi.org/10.1101/2021.06.03.21258241 doi: medRxiv preprint then sectioned with a microtome sequentially for various stains, including hematoxylin-eosin (HE) and in situ hybridization, as mentioned below.

The fresh-cut, 1-μm-thick TMA sections were deparaffinized in xylene and then dehydrated with 100% ethanol. FISH was performed on the sections with the RNAscope® Multiplex Fluorescent Reagent Kit v2 assay (Advanced Cell Diagnostics, Inc., Hayward, California), based on the assay principle as described 17 . Briefly, we incubated the tissue sections with H 2 O 2 and performed a heat-induced target retrieval step followed by protease incubation with the reagents provided. RNA sequences of SARS-CoV-2 S gene, SARS-CoV-2 antisense of S gene, ACE2, and TMPRSS2 were hybridized using RNAscope® probe -V-nCoV2019-S (#848561-C1), -V-nCoV2019-Ssense (#845701-C1), -Hs-ACE2-C2 (#848151-C2) and -Hs-TMPRSS2-C2 (#470341-C2), respectively. Positive (C1: POLR2A gene of Homo sapiens; C2: PPIB gene of Homo sapiens) and negative probes (dap gene of Bacillus subtilis) were also applied in each experiment. After the amplifier steps, according to the manual, Opal TM 570 and 650 fluorophores (PerkinElmer Life and Analytical Sciences, Boston, MA) were applied to the tissues incubated with C1 and C2 probes, respectively. Finally, nuclei were labeled with DAPI, and the slides were mounted with ProLong TM Gold antifade reagent (Invitrogen, Waltham, MA). Sections were analyzed with Zeiss Axio Imager 2 and image analysis software (ZEN 3·0 blue edition).

Samples prepared for transmission electron microscopy were obtained after 7-10 days of formalin fixation and additional fixation in 3% glutaraldehyde for 24 hours.

Samples were post-fixed in 1% OsO 4 (Roth, Karlsruhe, Germany) and dehydrated in All rights reserved. No reuse allowed without permission.

(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted June 5, 2021. ; https://doi.org/10.1101/2021.06.03.21258241 doi: medRxiv preprint ascending ethanol series (30, 50, 70, 90, and 100%) . Dehydrated samples were incubated in propylene oxide (Serva, Heidelberg, Germany) and embedded in Epon resin (Serva, Heidelberg, Germany). Ultrathin sections were contrast-enhanced by staining with 0.5% uranyl acetate and 1% lead citrate (both EMS, Munich, Germany) and viewed on a transmission electron microscope (Zeiss Leo 906, Oberkochen,

Germany).

We selected autopsy lung samples from a cohort of 3 patient groups, which were diagnosed as ARDS, COVID-19, and influenza A virus subtype H1N1 infection (Table   2 ). Briefly, 4 μ m thin FFPE sections were prepared and deparaffinized in xylene, followed by rehydration with a concentration gradient of ethanol. Tissue sections were then subjected to heat-induced epitope retrieval with Tris-EDTA buffer (pH 9) and quenched with 3% H 2 O 2 . The slides were then incubated with primary antibody against SARS spike glycoprotein (1:1000; Abcam, Cambridge, UK; Ab272420) in 1% BSA/PBS solution. The remaining IHC steps were performed as previously described 18 , and the staining was developed with ImmPACT® VIP Substrate (Vector Labs, Burlingame, CA, US). (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. Previously we compared two different kits for RT-PCR analysis 19 . Here, we used the TaqMan™ Fast 1-Step Master Mix (Thermo Fisher Scientific GmbH, Dreieich, Germany) for the qualitative detection of the E gene (encoding envelope protein) of severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) by a primer (0·4 μ M) and probe (0·2 μ M) set labeled with fluorescent reporters and quencher dyes. We used TaqMan® Exogenous Internal Positive Control reagents (Thermo Fisher Scientific GmbH, Dreieich, Germany) as internal PCR controls. RT-PCR was performed as previously described 19, 20 . Briefly, we reversely transcribed (50°C for 10 min) and amplified the RNA extracted from FFPE tissues with the reaction mixture at 95°C for 20 s and followed by 45 cycles of 95°C for 3 s and 58°C for 30 s. We used the Amplirun® SARS-CoV-2 RNA control (Bestbion dx GmbH, Cologne, Germany) provided with 13000 viral RNA copies μ L -1 to calculate the viral RNA copies in the tissue samples. In our SARS-CoV-2 positive tissues, the third quartile of the detectable viral copies is 328 viral copies μ L -1 , which is equivalent to the Ct value of 30·7. In this regard, we defined the cut-off value indicating a high viral load of SARS-CoV-2 in the sample when the Ct value was ≤ 30·7.

All rights reserved. No reuse allowed without permission.

(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted June 5, 2021. ; https://doi.org/10.1101/2021.06.03.21258241 doi: medRxiv preprint

The main characteristics of the study cohort (5 male/ 3 female; median age 69 [55-83] years) are given in Table 1 . The period between the onset of symptoms and death ranged from 12 to 64 days (median 31 days, Figure 1 ), thereby including early and late/prolonged disease stages. The time between the onset of symptoms and admission ranged from 1 to 7 days (median 5 days, Figure 1 ) and from admission to death from 2 to 60 days (median 26·5 days, Figure 1 ). Six patients had at least one clinically confirmed comorbidity, including hypertension (n=5), diabetes mellitus type 2 (n=3) or type 1 (n=1), coronary artery disease (n=2), malignant disease (n=1), liver cirrhosis (n=1) and dementia (n=1). One patient had a history of chronic kidney disease with kidney transplant and immunosuppression. One patient had a history of tobacco abuse, while no information on current or previous tobacco abuse was available for the remaining 7 patients. None of the patients had tested positive for the respiratory syncytial virus or influenza A and B viruses on admission. Seven patients were treated with mechanical ventilation, of which three patients were treated with additional extracorporeal membrane oxygenation (ECMO) subsequently. One patient refused mechanical ventilation and intensive care treatment. Duration of ECMO treatment ranged from 342 to 1381 hours (median 568 hours). During treatment, five patients had an acute kidney injury and required dialysis. None of the patients had a cerebrovascular disease or chronic obstructive pulmonary disease (COPD).

From the autopsy analyses, the direct cause of death in all patients was diffuse alveolar damage (DAD) with mixed and overlapping patterns of the exudative, All rights reserved. No reuse allowed without permission.

(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted June 5, 2021. ; https://doi.org/10.1101/2021.06.03.21258241 doi: medRxiv preprint proliferative, and organizing phase or fibrotic phase (Supplementary Table 2 ). All patients had heavier lungs compared to the normal range (median left: 945 g and right: 1191 g, normal: 500-700 g). Intra-alveolar granulocyte infiltration indicating bacterial superinfection was found in the majority of cases (5/8). Additionally, squamous metaplasia (6/8) and multinucleated intra-alveolar giant cells (5/8) were found. Two patients displayed pulmonary artery thrombosis. Some common findings in other organs were ductular cholestasis in the liver (5/8) and cardiomegaly (6/8; median 482 g). All pathological diagnostic data are summarized in Supplementary Table 2 .

Pulmonary findings of DAD included hyaline membranes, intra-alveolar edema, proliferative DAD after a disease duration of <21 days in three patients and organizing or fibrotic DAD with bronchiolization and squamous metaplasia after a disease duration of >21 days in five patients (Supplementary Table 2 Figure 2 ). In three additional All rights reserved. No reuse allowed without permission.

(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted June 5, 2021. ; https://doi.org/10.1101/2021.06.03.21258241 doi: medRxiv preprint patients with a disease duration of 12-64 days, CD3 positive lymphocytes were increased to ≥ 10/ mm² (patient 3 and 8, 10 CD3+ cells/mm 2 and patient 7, 11 CD3+ cells/ mm 2 ). In two of these three cases, the cardiac tissue was positive for SARS-CoV-2 RNA (Ct value ≤ 30 in patient 3 and Ct value ≥ 30 in patient 7, Figure 2 ). In the five cases with increased CD3 lymphocytes, also intravascular lymphocytes were increased, consistent with capillaritis (or endotheliitis). In all cases, we found an increased number of intra-and perivascular CD68 positive macrophages. Myocyte injury was not found in any case. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. Figure 1A-E) . We also validated the probes against the SARS-CoV-2 All rights reserved. No reuse allowed without permission.

(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted June 5, 2021. ; https://doi.org/10.1101/2021.06.03.21258241 doi: medRxiv preprint S gene and human ACE2 gene on autopsy lung tissue collected from an influenza A (H1N1) infected patient before the COVID-19 pandemic, showing no signal for SARS-CoV-2 S gene and prominent signal for ACE2 (Supplementary Figure 1F) .

FISH was performed to analyze tissue microarrays (TMA), followed by HE staining on consecutive slides for the overlay to allow a detailed morphological correlation 

We have identified several respiratory cells that were positive for SARS-CoV-2 genomic (S gene; sense) and replicating (S gene: antisense) RNA, ACE2, and TMPRSS2. This included the bronchial and alveolar epithelial cells and cells of the squamous metaplasia in the lung ( Figure 4A and 4E, Supplementary Figure 2A ). In the microvasculature, SARS-CoV-2 genomic and replicating RNA could be found in the endothelial cells together with ACE2 and TMPRSS2 ( Figure 4B ). SARS-CoV-2 genomic and replicating RNA, and TMPRSS2 RNA was also detected in the endothelium adjacent to emboli within vessels ( Figure 4C ). All rights reserved. No reuse allowed without permission.

(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. In the patients with pulmonary metastases from breast cancer and papillary thyroid cancer, some of the cancer cells were positive for SARS-CoV-2 genomic and replicating RNA, ACE2, and TMPRSS2 RNA (Supplementary Figure 2B-2C) .

In one lung sample, giant cells were positive for SARS-CoV-2 genomic and replicating RNA, and few were positive for ACE2 RNA (Supplementary Figure 2D) .

FISH also indicated some neutrophils to be positive for SARS-CoV-2 genomic and replicating RNA, ACE2, and TMPRSS2 RNA (Supplementary Figure 2E) .

Furthermore, hyaline membranes were positive for SARS-CoV-2 genomic and replicating RNA ( Figure 4D ), likely originating from detached pneumocytes. Finally, we showed that SARS-CoV-2 genomic and replicating RNA, and TMPRSS2 RNA were found in tracheal epithelial cells ( Figure 4F ).

, and TMPRSS2 in the heart, lymphoid organs, and urogenital tract.

Using PCR, we detected SARS-CoV-2 RNA in six of the eight patients in the heart ( Figure 2 ). We found both SARS-CoV-2 genomic and replicating RNA to be present in cardiomyocytes showing that the virus can infect and replicate in cardiomyocytes ( Figure 5A ). ACE2 was mainly expressed in the stromal cells, and capillary endothelial cells, whereas TMPRSS2 expression was mainly found in perivascular cells and some cardiomyocytes ( Figure 5A ).

In tonsils, we detected SARS-CoV-2 genomic and replicating RNA in the epithelium, which also expressed ACE2 and TMPRSS2 ( Figure 5B ; lower panel). Some lymphocytes also showed replicating SARS-CoV-2 RNA ( Figure 5B; upper panel) .

We also observed that ACE2 and TMPRSS2 RNA were expressed by some All rights reserved. No reuse allowed without permission.

(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. By RT-PCR, we detected a high viral load of SARS-CoV-2 in the testicles. FISH staining indicated SARS-CoV-2 genomic and replicating RNA to be localized mainly in the germinal epithelium ( Figure 6C ). Some endothelial cells were also infected by the virus. We observed ACE2 RNA was mainly expressed in the Leydig cells and some endothelial cells, whereas TMPRSS2 was mainly found in the stromal cells. All rights reserved. No reuse allowed without permission.

(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted June 5, 2021. ; https://doi.org/10.1101/2021.06.03.21258241 doi: medRxiv preprint SARS-CoV-2 antisense RNA could also be found in stromal cells of the ovary in one COVID-19 patient (Figure 6D) , where ACE2 RNA was also mainly expressed, and some stromal cells expressed TMPRSS2 RNA. In the two adrenal glands, we observed SARS-CoV-2 genomic and replicating SARS-CoV-2 RNA in most glandular epithelial cells ( Figure 7B ) and to a lesser extent in stromal and endothelial cells. ACE2 RNA expression was mainly found in most endothelial cells. TMPRSS2 RNA was mainly expressed in glandular epithelial cells ( Figure 7B ) and some endothelial cells.

In the salivary gland, SARS-CoV-2 genomic and replicating RNA were detected in most acini and salivary ducts together with strong detection of ACE2 and TMPRSS2 RNA ( Figure 7C ). SARS-CoV-2 genomic RNA was also found in some stromal cells and endothelial cells. ACE2 RNA expression was found in some stromal cells and most endothelial cells but TMPRSS2 RNA was not found in these two cell types.

Within the small bowel, SARS-CoV-2 genomic and replicating SARS-CoV-2 RNA were mainly detected in the enterocytes, accompanied by strong expression of ACE2 All rights reserved. No reuse allowed without permission.

(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted June 5, 2021. ; https://doi.org/10.1101/2021.06.03.21258241 doi: medRxiv preprint and TMPRSS2 RNA ( Figure 7C ). Additionally, ACE2 RNA expression was found in mesenchymal stromal cells, muscle cells expressed both ACE2 and TMPRSS2 RNA.

In the endothelial cells, we detected ACE2 but not TMPRSS2 RNA.

In the pancreas, we detected genomic and replicating SARS-CoV-2 RNA in most acinar cells, which colocalized with strong expression of ACE2 and TMPRSS2 RNA ( Figure 7D ). SARS-CoV-2 genomic RNA was also detectable in some stromal and endothelial cells. ACE2 RNA was present in most stromal cells and some endothelial cells, while TMPRSS2 RNA was only present in some stromal cells.

We detected genomic and replicating SARS-CoV-2 RNA in the skeletal muscle, mainly localized in the myocytes ( Figure 7E ) and some endothelial cells. Moreover, the muscle cells also expressed ACE2 RNA and TMPRSS2 RNA. In the endothelial cells, we observed ACE2 RNA expression but not TMPRSS2 RNA.

Finally, we detected both SARS-CoV-2 genomic and replicating RNA in the dermal epithelial cells ( Figure 7F ). The epithelial cells also expressed ACE2 and TMPRSS2, while mRNA for both proteins was only sparsely detected in endothelial cells.

Protein detection of SARS-CoV-2 spike glycoprotein is widely used in studies in FFPE tissues. We stained for the SARS-CoV-2 spike glycoprotein in the COVID-19 autopsy lung and selected the most commonly used antibodies based on previous studies 19, 22 , targeting the SARS spike glycoprotein (Abcam, ab272420) and SARS-CoV SΔ10 within S2 domain protein (Genetex, GTX632604). We have tested these two antibodies on FFPE autopsy lung tissues with four different antigen retrieval methods as outlined in the methods section. All approaches were unsuccessful, i.e., no positive signals could be observed, except the ab272420 using Tris-EDTA buffer All rights reserved. No reuse allowed without permission.

(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted June 5, 2021. ; https://doi.org/10.1101/2021.06.03.21258241 doi: medRxiv preprint (pH 9) antigen retrieval. We validated this protocol on autopsy lung tissues from our COVID-19 cohort and non-COVID-19 cases as negative controls, including 1) four patients infected with influenza, 2) six patients who developed ARDS (selected nonsuperinfected areas), and 3) six patients who had no pulmonary pathology ( Table 2) . 

Ultrastructural tissue preservation in autopsy material was rather poor and hampered virus particle detection by electron microscopy. Autolytic processes before fixation led to cell degradation and strong autolytic vesicle formation, resulting in many virus-like particles, but not a single reliable SARS-CoV-2 detection, despite a thorough analysis of all cases (data not shown).

FISH requires fluorescence microscopes, which might not be available in all pathologies performing autopsies, and the signal also faints with time. Therefore, we also established the chromogenic in situ hybridization (CISH) for SARS-CoV-2 detection (Supplementary method, Supplementary table 3) . We first validated the CISH detection with the same positive and negative control probes used in FISH All rights reserved. No reuse allowed without permission.

(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. 

We here comprehensively analyzed SARS-CoV-2 in tissues from clinical autopsies of COVID-19 cases. We compared various methods, suggesting the most effective and useful approaches for SARS-CoV-2 detection in autopsy tissues, focusing on routine processing in pathology and thereby possibly the most wide spread adoption of the methods. Using these methods, we have comprehensively analyzed a multitude of tissues and cells for SARS-CoV-2 presence to perform a detailed correlation of virus presence and potential pathology findings. We describe virus spread in several tissues (i.e., thyroid, adrenal gland, prostate, large bowel and ovary) previously not described and pin-point the localization to specific cells within each tissue.

Comparing various approaches routinely used in pathology institutes, the RNA detection methods (either by RT-PCR, FISH or CISH) were proved to be the most effective, specific, and suitable to use. In contrast, both immunohistochemistry and All rights reserved. No reuse allowed without permission.

(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted June 5, 2021. ; https://doi.org/10.1101/2021.06.03.21258241 doi: medRxiv preprint electron microscopy turned out not to be suitable, confirming previous reports 11, 23, 24 .

When using RNA-based methods, a 2-step approach could be applied. First, screening the cases and tissues using the RT-PCR, followed by a more complex and time-consuming FISH approach only in positive tissues. We focused our approach on FFPE tissue since this is internationally the most widely adopted tissue processing in institutes of pathology and autopsy centers. Although formalin fixation and paraffin embedding might lead to additional RNA degradation, FFPE material has the important advantage of not being infectious and conservable, which makes further processing much easier and more broadly applicable compared to, e.g., fresh infectious tissue. Further, reliable detection in FFPE materials allows for fast retrospective analysis, as FFPE blocks are regularly archived and widely available in all institutes of pathology.

Compared to RT-PCR, the ISH detection method in FFPE autopsies could avoid the interference of SARS-CoV-2 RNA in the blood that remained within the tissues 9 . To precisely localize the signal, consecutive sections can be used, allowing a very detailed association of morphology with positive signals, which is not possible in FISH or CISH sections alone. Apart from the precise localization, the FISH approach also allows colocalizing analysis of the viral RNA and its targets ACE2 and TMPRSS2 on the cellular level. Compared to FISH, the CISH method has some advantages, particularly not requiring fluorescence microscopy equipment, which might not be readily available in all institutes, longer stability of the signals, and the possibility of a faster digitalization of the slides using whole-slide scanners. On the other hand, the FISH signals are easier to detect and provide a much better signal-tonoise ratio by adjusting the fluorescence excitation. Validation of the ISH on an independent external cohort in our study confirmed its broad applicability. All rights reserved. No reuse allowed without permission.

(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. all extra-respiratory organs, we were not able to identify specific pathological alterations that would be attributable to viral infection. We cannot exclude subtle or molecular changes that were not translating to the morphological changes presented in the infected non-respiratory tissues. However, our detailed analyses might suggest that the SARS-CoV-2 spreading beyond the respiratory tract does not induce any major pathology and might be rather negligible in comparison to the pulmonary involvement, at least in fatal cases. Similar conclusions were also suggested in some previous reports 10, 20, 29 .

One hypothesis for the multisystemic nature of COVID-19 is the systemic spread and effects on the (micro)vasculature 30 . We show SARS-CoV-2 genomic and replicating RNA and particularly TMPRSS2 RNA in the endothelial cells of vessels across all organs, supporting this hypothesis. This, is supported by data showing SARS-CoV-2 RNA in the blood 31 . Besides, we also found the viral RNA in vessels across all organ systems and pulmonary endothelial cells adjacent to thrombi, which might be a hint to All rights reserved. No reuse allowed without permission.

(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted June 5, 2021. ; https://doi.org/10.1101/2021.06.03.21258241 doi: medRxiv preprint the microvascular damage induced by direct endothelial infection 10 . However, we have only found vasculature with thrombi in the lungs, but not in any other of the analyzed organs or tissues. This might be influenced by our relatively small cohort, mainly consisting of intensive care unit patients who had been receiving anticoagulative treatment. We have also been very cautious regarding the interpretation of vascular occlusion as intravital thrombotic events in order not to false-positively interpret post-mortem clots as intravital thrombi.

We showed the predominance of viral RNA in ACE2 and/or TMPRSS2-expressing epithelial cells compared to mesenchymal stromal cells and endothelial cells in various organs. This included e.g., trachea, lung, tonsil, salivary glands, kidney, and small bowel. The presence of SARS-CoV-2 RNA in salivary glands supports the effectiveness of saliva-based SARS-CoV-2 testing that has been emerged worldwide 32 . We also showed the presence of viral RNA in non-epithelial tissues, such as lymph nodes, heart, and skeletal muscle 20, [33] [34] [35] . We visualized for the first time (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted June 5, 2021. ; https://doi.org/10.1101/2021.06.03.21258241 doi: medRxiv preprint morbidity and mortality of cancer patients after being infected with the SARS-CoV-2 virus 42 .

We could also confirm the presence of ACE2 receptor on alveolar epithelial cells 43 and pancreatic ductal cells 44 as well as TMPRSS2 on salivary acinar cells 45 and prostate epithelial cells 46 as previously suggested by single-cell RNA sequencing studies.

Our study has several limitations. We have not found viral presence in a few of the analyzed tissues, including bone marrow, esophagus, large bowel, and spleen. This might be due to the low number of analyzed patients. We aimed to perform a detailed analysis and cellular localization, which in the absence of reliable protein or ultrastructural detection, required to perform FISH analysis. This method is timeconsuming, particularly when using co-localization with consecutive sections, making it hard to apply in a large number of cases. Therefore, for more high-throughput approaches, we suggest pre-screening of the cases and tissues using RT-PCR.

Our study is descriptive, provides a single time-point analysis of only fatal cases.

However, these are intrinsic limitations of autopsy studies. On the other hand, there are no other approaches that would allow analyzing comprehensively all human tissues in a comparable way. The variable degrees of autolysis in some tissue samples might limit the efficacy of viral detection. This was particularly true for electron microscopy, which was not applicable in our hands. Methodologically, in some cell types with scarce cytoplasm and overlap with neighbouring cells, it was not possible to allocate the ISH signal localization to a particular cell. We found a small population of SARS-CoV-2 positive cells that were negative for ACE2 or TMPRSS2

RNA. This is most likely due to a sampling bias, given that the FISH or CISH slides are extremely thin and only reflect part of the volume of the cells. An alternative All rights reserved. No reuse allowed without permission.

(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted June 5, 2021. ; https://doi.org/10.1101/2021.06.03.21258241 doi: medRxiv preprint explanation might be that SARS-CoV-2 was suggested to enter host cells independently of ACE2 and TMPRSS2 47 . Regarding the wide spread of SARS-CoV-2 variants lately, it is unclear whether our RNA-targeted approaches would detect or being interfered by the mutations, despite the fact that a pool of probes for detecting different genomic sites of the SARS-CoV-2 is used in our FISH method.

In conclusion, our present study suggests that RT-PCR and FISH performed on FFPE tissues are reliable methods allowing tissue and cellular localization in autopsies. We provide a "cellular and whole body tissue atlas" of organ tropism profile of SARS-CoV-2 in severe COVID-19 patients, suggesting a multisystemic spread in virtually all cell types of infected organs. All rights reserved. No reuse allowed without permission.

(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. 

The excellent technical help of Inge Losen and Simon Otten is gratefully acknowledged. We wish to thank all relatives and legal representatives for giving their consent for the autopsy procedure. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted June 5, 2021. ; https://doi.org/10.1101/2021.06.03.21258241 doi: medRxiv preprint

The authors declare that there is nothing to disclose. All rights reserved. No reuse allowed without permission.

(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.

(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The disease course of each of the eight COVID-19 patients is shown from disease onset until death.

Hospital admission was denoted as day 0, the therapies are color-coded. Patient 1 had the shortest time between the beginning of symptomatic disease and death, i.e. six days, while patient 8 had the longest disease course till death with eight weeks of mechanical ventilation. All rights reserved. No reuse allowed without permission.

(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. Not available = tissue does not contain cell type All rights reserved. No reuse allowed without permission.

(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted June 5, 2021. ; https://doi.org/10.1101/2021.06.03.21258241 doi: medRxiv preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted June 5, 2021. ; https://doi.org/10.1101/2021.06.03.21258241 doi: medRxiv preprint lymphocytes/ immune cells; lower panel: local small salivary gland epithelium) and lymph node (C, upper panel: capillary with endothelial lining; lower panel: lymphocytes/ immune cells). Scale bars represent 200, 50 and 20 µm, respectively. All rights reserved. No reuse allowed without permission.

(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted June 5, 2021. ; https://doi.org/10.1101/2021.06.03.21258241 doi: medRxiv preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted June 5, 2021. ; https://doi.org/10.1101/2021.06.03.21258241 doi: medRxiv preprint All rights reserved. No reuse allowed without permission.

(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted June 5, 2021. ; https://doi.org/10.1101/2021.06.03.21258241 doi: medRxiv preprint

Frequency, signs and symptoms, and criteria adopted for long COVID: a systematic review

Acute myocardial injury is common in patients with COVID-19 and impairs their prognosis

Autopsy findings in COVID-19-related deaths: a literature review

Sensitive visualization of SARS-CoV-2 RNA with CoronaFISH

Antemortem vs. postmortem histopathological and ultrastructural findings in paired transbronchial biopsies and lung autopsy samples from three patients with confirmed SARS-CoV-2 infection

Immunohistochemical, in situ hybridization, and ultrastructural localization of SARS-associated coronavirus in lung of a fatal case of severe acute respiratory syndrome in Taiwan

Visualization of SARS-CoV-2 in the Lung. Reply

Lung transplantation for patients with severe COVID-19

Evidence of Severe Acute Respiratory Syndrome Coronavirus 2 Replication and Tropism in the Lungs, Airways, and Vascular Endothelium of Patients With Fatal Coronavirus Disease 2019: An Autopsy Case Series

Persistence of viral RNA, pneumocyte syncytia and thrombosis are hallmarks of advanced COVID-19 pathology

Comparison of RNA In Situ Hybridization and Immunohistochemistry Techniques for the Detection and Localization of SARS-CoV-2 in Human Tissues

Viral presence and immunopathology in patients with lethal COVID-19: a prospective autopsy cohort study

COVID-19-associated nephropathy includes tubular necrosis and capillary congestion, with evidence of SARS-CoV-2 in the nephron

Detection of SARS-CoV-2 in formalin-fixed paraffin-embedded tissue sections using commercially available reagents

All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted

RNAscope: a novel in situ RNA analysis platform for formalin-fixed, paraffin-embedded tissues

Cellular and Molecular Mechanisms of Kidney Injury in 2,8-Dihydroxyadenine Nephropathy

SARS-CoV-2 RNA screening in routine pathology specimens

Unspecific post-mortem findings despite multiorgan viral spread in COVID-19 patients

Clinical features of macrophage activation syndrome as the onset manifestation of juvenile systemic lupus erythematosus

Histopathology and ultrastructural findings of fatal COVID-19 infections in Washington State: a case series

Hunting coronavirus by transmission electron microscopy -a guide to SARS-CoV-2-associated ultrastructural pathology in COVID-19 tissues

A systematic review of pathological findings in COVID-19: a pathophysiological timeline and possible mechanisms of disease progression

The evolution of pulmonary pathology in fatal COVID-19 disease: an autopsy study with clinical correlation

Pulmonary pathology of severe acute respiratory syndrome in Toronto

Lung pathology of fatal severe acute respiratory syndrome

Neuropathology of patients with COVID-19 in Germany: a post-mortem case series

Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19

Risk factors for SARS-CoV-2 detection in blood of critically ill patients

Saliva as a gold-standard sample for SARS-CoV-2 detection. The Lancet Respiratory Medicine

SARS-CoV-2 infection of the oral cavity and saliva

Molecular Detection of SARS-CoV-2 Infection in FFPE Samples and Histopathologic Findings in Fatal SARS-CoV-2 Cases

Clinical Characteristics and Results of Semen Tests Among Men With Coronavirus Disease

Pathological Findings in the Testes of COVID-19 Patients: Clinical Implications

Histopathological findings and viral tropism in UK patients with severe fatal COVID-19: a post-mortem study

Autopsy Findings and Venous Thromboembolism in Patients With COVID-19: A Prospective Cohort Study

Pathology of the thyroid in severe acute respiratory syndrome

SARS-CoV-2 detection in formalin-fixed paraffin-embedded tissue specimens from surgical resection of tongue squamous cell carcinoma

SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes

Expression of SARS-CoV-2 Entry Factors in the Pancreas of Normal Organ Donors and Individuals with COVID-19

Systematic analysis of ACE2 and TMPRSS2 expression in salivary glands reveals underlying transmission mechanism caused by SARS-CoV-2

Expression of ACE2, the SARS-CoV-2 receptor, and TMPRSS2 in prostate epithelial cells

No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity